MarketPulse

misleading statements

282 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Mereo BioPharma Faces Class Action Over Failed Drug Trials and Misleading Statements

Mereo BioPharma faces class action over failed Phase 3 trials and alleged misleading statements. Investor deadline April 6, 2026.
MREOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Corcept Therapeutics Faces Securities Fraud Lawsuit Over Misleading FDA Claims

Schall Law Firm seeks investors in $COPT securities class action, alleging false statements about relacorilant FDA approval prospects between October 2024 and December 2025.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

PomDoctor Securities Class Action: April 7 Deadline Looms for Defrauded Investors

Rosen Law Firm alerts $POM investors of April 7, 2026 lead plaintiff deadline in securities fraud lawsuit alleging false statements and manipulative trading schemes.
POMsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Class Action Lawsuits Filed Against $POMD and $INO Over Fraud Allegations

Class actions filed against PomDoctor for stock promotion fraud and Inovio for misleading regulatory claims. Inovio stock plunged 24.45% after FDA rejection.
INOPOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Soleno Therapeutics Faces Class Action Over Alleged PWS Drug Safety Misstatements

Class action lawsuit filed against $SLNO alleging false statements about DCCR safety concerns and commercial viability for Prader-Willi syndrome treatment.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Enphase Energy Executives Face Personal Liability in Securities Lawsuit Over Disclosure Failures

Enphase Energy CEO and CFO named as defendants in securities class action over alleged misleading statements regarding inventory levels and 25D Credit impact.
ENPHrevenue guidancesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Snowflake Faces Major Securities Lawsuit Over Misleading Revenue Guidance

Securities class action filed against $SNOW alleging officers made materially misleading statements about revenue growth and 2029 targets, triggering 18% stock decline.
SNOWsecurities fraudstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Gene Therapy Giant REGENXBIO Faces Class Action Over RGX-111 Misstatements

Class action lawsuit filed against REGENXBIO alleging false statements about RGX-111 gene therapy. Covers investors from Feb 2022 to Jan 2026; lead plaintiff deadline April 14.
RGNXsecurities fraudclass action lawsuit
BenzingaBenzinga··Business Wire

OLMA Stock Plummets 19.6% Amid Securities Investigation Over Undisclosed Trial Risks

DJS Law Group investigates Olema Pharmaceuticals for potential securities violations following failed Roche trial, triggering sharp stock decline.
OLMAstock declinemisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Law Offices Of Howard G. Smith

Four Companies Face Securities Fraud Lawsuits; Investors Have Until March 2026 to Join Class Actions

Law Offices of Howard G. Smith filed securities fraud class actions against $SDM, $BRBR, $METC, and $CLEUF, alleging market manipulation and misrepresentation. Lead plaintiff deadline: late March 2026.
BRBRSDMMETCMETCBMETCI+2securities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Navan Stock Crashes 63% Amid Securities Fraud Lawsuit Over Hidden Expenses

Navan stock plunges 63% following securities fraud allegations over undisclosed $95M sales expense spike and CFO departure post-IPO.
NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

PayPal Faces Securities Fraud Lawsuit Over Overstated Checkout Capabilities

PayPal shareholders can file claims in securities fraud class action alleging material misstatements about Branded Checkout. Stock plummeted 20.3% following surprise CEO departure and weak earnings.
PYPLsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Oracle Faces Class Action Over Undisclosed AI CapEx Surge, Stock Tumbles

Oracle faces class action lawsuit alleging undisclosed AI infrastructure costs and revenue mismatches. Stock declined following missed earnings, delayed data centers, and partner withdrawal.
ORCLORCLpDsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Varonis Stock Plunged 48% After Disclosure: Securities Lawsuit Seeks Lead Plaintiff

Varonis faces class action lawsuit over alleged concealment of 63.9% term license revenue decline. Stock crashed 48%, erasing $3.8 billion in value.
VRNSsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Vistagen Investors Pursue Securities Fraud Claims Over Misleading Drug Trial Statements

Schall Law Firm seeks Vistagen investors in class action over alleged false statements regarding fasedienol drug candidate's Phase 3 trial prospects.
VTGNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Biotech Giants Face Class Action Suits After Failed Bone-Disease Trials Crater Stock Prices

Class action suits filed against Ultragenyx and Mereo BioPharma following failed Phase III trials for setrusumab, with stock prices crashing 42.32% and 87.7% respectively.
MREORAREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

BlackRock TCP and Plug Power Face Class Action Suits Over Disclosure Failures

Class actions filed against BlackRock TCP and Plug Power over alleged disclosure failures—BlackRock TCP faces NAV understatement claims following 19% decline; Plug Power accused of overstating DOE funding prospects.
PLUGTCPCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

NuScale Faces Class Action Lawsuit Over Partner Misrepresentations Amid $495M Payment

Robbins Geller files class action against NuScale Power for allegedly misrepresenting commercialization partner ENTRA1's nuclear experience, triggering 12% stock decline.
SMRFLRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Ultragenyx Hit With Class Action Over Setrusumab Data Misrepresentation

Class action lawsuit filed against $UGXY alleging securities fraud over misleading setrusumab trial data and OI patient safety disclosures.
RAREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Plug Power Hit With Class Action Over DOE Loan Claims and Project Viability

Class action lawsuit filed against $PLUG alleging false statements about DOE funding and hydrogen facility prospects between January and November 2025.
PLUGsecurities fraudclass action lawsuit